• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

66岁及以上患者的动脉瘤性蛛网膜下腔出血的预后

Outcome of aneurysmal subarachnoid hemorrhage in patients 66 years of age and older.

作者信息

Muizelaar J P, Vermeulen M, van Crevel H, Hijdra A, van Gijn J, Teasdale G M, Lindsay K W, Murray G D

机构信息

Division of Neurosurgery, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0001.

出版信息

Clin Neurol Neurosurg. 1988;90(3):203-7. doi: 10.1016/0303-8467(88)90022-4.

DOI:10.1016/0303-8467(88)90022-4
PMID:3197345
Abstract

The outcome at three months after aneurysmal SAH in a group of older patients and a group of younger patients is compared. The patients were admitted within 72 hours of their SAH. Of 61 patients 66 years of age and older, comprising 13% of the whole patient group, 52% died, 12% remained dependent and 36% became independent. In the younger group, 55% had an independent outcome (p less than 0.01). In contrast to what we expected in the older patient group, not extracranial, but intracranial events (re-bleeds, infarcts, hydrocephalus) were by far the most frequent cause of deterioration.

摘要

比较了一组老年患者和一组年轻患者动脉瘤性蛛网膜下腔出血(SAH)三个月后的结局。这些患者在SAH发作后72小时内入院。在61名66岁及以上的患者中,占整个患者组的13%,52%死亡,12%仍有依赖,36%恢复独立。在较年轻的组中,55%有独立的结局(p<0.01)。与我们在老年患者组中的预期相反,导致病情恶化的最常见原因不是颅外事件,而是颅内事件(再出血、梗死、脑积水)。

相似文献

1
Outcome of aneurysmal subarachnoid hemorrhage in patients 66 years of age and older.66岁及以上患者的动脉瘤性蛛网膜下腔出血的预后
Clin Neurol Neurosurg. 1988;90(3):203-7. doi: 10.1016/0303-8467(88)90022-4.
2
Tranexamic acid in subarachnoid hemorrhage. A double-blind study.氨甲环酸治疗蛛网膜下腔出血:一项双盲研究。
Stroke. 1979 Sep-Oct;10(5):519-22. doi: 10.1161/01.str.10.5.519.
3
Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial.氨甲环酸对蛛网膜下腔出血后再出血的影响:一项双盲对照临床试验。
Ann Neurol. 1977 Sep;2(3):238-42. doi: 10.1002/ana.410020310.
4
Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm.颅内动脉瘤破裂所致蛛网膜下腔出血的抗纤溶治疗
Neurology. 1981 Mar;31(3):316-22. doi: 10.1212/wnl.31.3.316.
5
Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial.氨甲环酸治疗颅内动脉瘤破裂所致蛛网膜下腔出血:一项双盲临床试验。
Ann Neurol. 1978 Jun;3(6):502-4. doi: 10.1002/ana.410030607.
6
Antifibrinolytic therapy in patients with aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study.动脉瘤性蛛网膜下腔出血患者的抗纤溶治疗。合作动脉瘤研究报告。
Arch Neurol. 1981 Jan;38(1):25-9. doi: 10.1001/archneur.1981.00510010051009.
7
Short-term tranexamic acid treatment in aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血的短期氨甲环酸治疗
Stroke. 1989 Dec;20(12):1674-9. doi: 10.1161/01.str.20.12.1674.
8
Preoperative management of patients with aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血患者的术前管理
J Neurosurg Sci. 1975 Jan-Jun;19(1-2):59-64.
9
Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial.氨甲环酸抗纤溶治疗动脉瘤性蛛网膜下腔出血:一项连续对照临床试验。
Neurosurgery. 1981 Feb;8(2):158-65. doi: 10.1227/00006123-198102000-00004.
10
Antifibrinolytic treatment in subarachnoid hemorrhage.蛛网膜下腔出血的抗纤溶治疗
N Engl J Med. 1984 Aug 16;311(7):432-7. doi: 10.1056/NEJM198408163110703.

引用本文的文献

1
Self-assessment of quality of life in patients after suffering from aneurysmal subarachnoid hemorrhage, principal component analysis.动脉瘤性蛛网膜下腔出血患者生活质量的自我评估,主成分分析
Sci Rep. 2025 Jul 16;15(1):25674. doi: 10.1038/s41598-025-11523-8.